Teriparatide

Chemical formula: C₁₈₁H₂₉₁N₅₅O₅₁S₂  Molecular mass: 4,116.134 g/mol 

Active ingredient description

Teriparatide (rhPTH(1-34)) is the active fragment (1-34) of endogenous human parathyroid hormone. Teriparatide is a bone formation agent to treat osteoporosis. The skeletal effects of teriparatide depend upon the pattern of systemic exposure.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code Group title Classification
H05AA02 Teriparatide H Systemic hormonal preparations, excl. Sex hormones and insulins → H05 Calcium homeostasis → H05A Parathyroid hormones and analogues → H05AA Parathyroid hormones and analogues
Discover more medicines within H05AA02

Product monographs

Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):

Title Information Source Document Type  
FORSTEO Solution for injection European Medicines Agency (EU) MPI, EU: SmPC
TERROSA Solution for injection Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
FORTEO Solution for injection FDA, National Drug Code (US) MPI, US: SPL/PLR

2D molecular structure

2D representation of the active ingredient's molecular structure

External identifiers

CAS Substance: 52232-67-4
DrugBank Drug: DB06285
KEGG Drug: D06078
RxNorm Ingredient: 32915
SNOMED-CT Concept: 425438001
Teriparatide (substance)
UNII Identifier: 10T9CSU89I
TERIPARATIDE

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.